Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07267871 · ClinicalTrials.gov registry record
Oura Blood Pressure Profile Study
A clinical trial, sponsored by Ouraring.
- Recruiting
- Registry status
- 2,000,000
- Enrollment target
NCT07267871: Recruiting study, sponsored by Ouraring.
NCT07267871 is a clinical trial that is actively recruiting participants, run by Ouraring. The registered enrollment target is 2,000,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07267871 is actively recruiting participants, sponsored by Ouraring.
- RECRUITING
- Registry status
- 2,000,000 participants
- Enrollment target
Study Summary
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000,000 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2027-05 |
What NCT07267871 shows while recruiting
NCT07267871 is an observational study that tracks outcomes without assigning an intervention. Its 2,000,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT07267871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07267871 about?
NCT07267871 is a clinical study titled "Oura Blood Pressure Profile Study". The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
What is the current status of trial NCT07267871?
This trial is currently recruiting. The enrollment target is 2,000,000 participants. The study started on 2025-12-17. Estimated completion is 2027-05.
Who is sponsoring clinical trial NCT07267871?
This trial is sponsored by Ouraring, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03813862 · 2,000,000 participants
Observational Pharmaco-Epidemiology Research & Analysis
- NCT06057181 · 2,000,000 participants
Helix Research Network
- NCT07022951 · 1,200,000 participants
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
- NCT06803498 · 3,000,000 participants
Delivery Room Intervention and Evaluation Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI